U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry MIXED
Molecular Formula C21H24O4
Molecular Weight 340.4129
Optical Activity UNSPECIFIED
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BISPHENOL A DIGLYCIDYL ETHER

SMILES

CC(C)(C1=CC=C(OCC2CO2)C=C1)C3=CC=C(OCC4CO4)C=C3

InChI

InChIKey=LCFVJGUPQDGYKZ-UHFFFAOYSA-N
InChI=1S/C21H24O4/c1-21(2,15-3-7-17(8-4-15)22-11-19-13-24-19)16-5-9-18(10-6-16)23-12-20-14-25-20/h3-10,19-20H,11-14H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C21H24O4
Molecular Weight 340.4129
Charge 0
Count
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 0 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Bisphenol A diglycidyl ether (BADGE) is a ligand for peroxisome proliferator-activated receptor gamma (PPARgamma); in addition, this compound can antagonize the ability of agonist ligands such as rosiglitazone to activate the transcriptional and adipogenic action of this receptor. The elevation of BADGE concentration in epoxy resins-coated aluminium tubes poses a risk of developing contact dermatitis to patients sensitized to epoxy resins.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
100.0 µM [IC50]
PubMed

PubMed

TitleDatePubMed
Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia.
2010-06
PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
2010-05-01
Field-amplified sample injection-micellar electrokinetic capillary chromatography for the analysis of bisphenol A, bisphenol F, and their diglycidyl ethers and derivatives in canned soft drinks.
2010-05
Analysis of reaction products of food contaminants and ingredients: bisphenol A diglycidyl ether (BADGE) in canned foods.
2010-04-28
Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gamma.
2010-04
Acute testis toxicity of bisphenol A diglycidyl ether in Sprague-Dawley rats.
2010-03
PPARgamma regulates LIF-induced growth and self-renewal of mouse ES cells through Tyk2-Stat3 pathway.
2010-03
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.
2010-02
Suppression effects of AICAR on insulin secretion involved in peroxisome proliferator-activated receptor gamma changes in INS-1 cells.
2010-01-27
Comparison and prediction of the retention in micellar electrokinetic chromatography and microemulsion electrokinetic chromatography for disubstituted benzenes.
2010-01
Clinical evaluation of resin-based composites in posterior restorations: 12-month results.
2010-01
Reduced sensitizing capacity of epoxy resin systems: a structure-activity relationship study.
2009-11
Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment.
2009-07-09
Repressive effect of the phytoestrogen genistein on estradiol-induced uterine leiomyoma cell proliferation.
2009-06
Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.
2009-06
Chemical and structural characterisation of DGEBA-based epoxies by time of flight secondary ion mass spectrometry (ToF-SIMS) as a preliminary to polymer interphase characterisation.
2009-04
Regulation of adipose triglyceride lipase by rosiglitazone.
2009-02
IgE-mediated occupational asthma from epoxy resin.
2009
Contamination of semi-solid dosage forms by leachables from aluminium tubes.
2008-11
Bisphenol A bis(2,3-dihydroxypropyl) ether (BADGE.2H2O) induces orphan nuclear receptor Nur77 gene expression and increases steroidogenesis in mouse testicular Leydig cells.
2008-07-31
Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.
2008-07
JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro.
2008-05
Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
2008-04
Concentrations of bisphenol a, bisphenol a diglycidyl ether, and their derivatives in canned foods in Japanese markets.
2008-03-26
Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
2008-03-12
4-tert-octylphenol regulates the differentiation of C3H10T1/2 cells into osteoblast and adipocyte lineages.
2008-03
Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content.
2008-01
PPARgamma Inhibitors as Novel Tubulin-Targeting Agents.
2008
Comparison of resolution in microemulsion EKC and MEKC employing suppressed electroosmosis: application to bisphenol-A-diglycidyl ether and its derivatives.
2007-10
Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
2007-09
Risk assessment of topically applied products.
2007-07-01
Developmental toxicity by exposure to bisphenol A diglycidyl ether during gestation and lactation period in Sprague-Dawley male rats.
2007-03
PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells.
2007-02-01
Trans-10, cis-12-conjugated linoleic acid increases phagocytosis of porcine peripheral blood polymorphonuclear cells in vitro.
2007-01
Bisphenol A (BPA) and its source in foods in Japanese markets.
2007-01
Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
2006-12
Neuroprotective effects of arachidonic acid against oxidative stress on rat hippocampal slices.
2006-11-07
Study on mutagenic effects of bisphenol A diglycidyl ether (BADGE) and its derivatives in the Escherichia coli tryptophan reverse mutation assay.
2006-10-10
Identification and estrogenic characterization of impurities in commercial bisphenol A diglycidyl ether (BADGE).
2006-10
Single laboratory validation of a method for the determination of Bisphenol A, Bisphenol A diglycidyl ether and its derivatives in canned foods by reversed-phase liquid chromatography.
2006-09-29
PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
2006-09
Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells.
2006-08-28
Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation.
2006-07
Stability of silorane dental monomers in aqueous systems.
2006-07
Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone.
2006-06
Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice.
2006-04
Determination of bisphenol diglycidyl ether residues in canned foods by pressurized liquid extraction and liquid chromatography-tandem mass spectrometry.
2006-02-24
Neuroprotective effects of stearic acid against toxicity of oxygen/glucose deprivation or glutamate on rat cortical or hippocampal slices.
2006-02
Effect of peroxisome proliferator-activated receptor-gamma ligands on the expression of retinoic acid-inducible gene-I in endothelial cells stimulated with lipopolysaccharide.
2005-12
Dietary exposure to chemical migrants from food contact materials: a probabilistic approach.
2005-10
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:34:54 GMT 2025
Edited
by admin
on Mon Mar 31 20:34:54 GMT 2025
Record UNII
F3XRM1NX4H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-5022
Preferred Name English
BISPHENOL A DIGLYCIDYL ETHER
HSDB   MI  
Systematic Name English
2,2'-(PROPANE-2,2-DIYLBIS(BENZENE-4,1-DIYLOXYMETHANEDIYL))DIOXIRANE
Systematic Name English
2,2'-(2,2-PROPANEDIYLBIS(4,1-PHENYLENEOXYMETHYLENE))DIOXIRANE
Systematic Name English
2,2-BIS(4-GLYCIDYLOXYPHENYL)PROPANE
Common Name English
4,4'-ISOPROPYLIDENEDIPHENOL DIGLYCIDYL ETHER
Systematic Name English
PROPANE, 2,2-BIS((P-2,3-EPOXYPROPOXY)PHENYL)-
Common Name English
BISPHENOL A DIGLYCIDYL ETHER [HSDB]
Common Name English
BADGE
Common Name English
BISPHENOL A DIGLYCIDYL ETHER [MI]
Common Name English
2,2'-(PROPANE-2,2-DIYLBIS(4,1-PHENYLENEOXYMETHYLENE))DIOXIRANE
Systematic Name English
DIGLYCIDYL BISPHENOL A ETHER
Common Name English
DGEBPA
Common Name English
DIGLYCIDYL ETHER OF 4,4'-ISOPROPYLIDENEDIPHENOL
Common Name English
2,2-BIS(4'-GLYCIDYLOXYPHENYL)PROPANE
Common Name English
BISPHENOL A DIGLYCIDYL ETHER [IARC]
Common Name English
2,2'-((1-METHYLETHYLIDENE)BIS(4,1-PHENYLENEOXYMETHYLENE))BISOXIRANE
Systematic Name English
BISPHENOL DIGLYCIDYL ETHER
Systematic Name English
DIGLYCIDYL ETHER OF 2,2-BIS(P-HYDROXYPHENYL)PROPANE
Common Name English
Classification Tree Code System Code
NDF-RT N0000185508
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
Code System Code Type Description
NDF-RT
N0000175629
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY Increased Histamine Release [PE]
MERCK INDEX
m2568
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY Merck Index
ECHA (EC/EINECS)
216-823-5
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
CAS
1675-54-3
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
NDF-RT
N0000171131
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY Allergens [Chemical/Ingredient]
PUBCHEM
2286
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
EPA CompTox
DTXSID6024624
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
DRUG BANK
DB14083
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
NDF-RT
N0000184306
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY Cell-mediated Immunity [PE]
EVMPD
SUB61066
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
FDA UNII
F3XRM1NX4H
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
WIKIPEDIA
BISPHENOL A DIGLYCIDYL ETHER
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
SMS_ID
100000134284
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
NSC
5022
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
DAILYMED
F3XRM1NX4H
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
RXCUI
1368138
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
HSDB
331
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
MESH
C019273
Created by admin on Mon Mar 31 20:34:54 GMT 2025 , Edited by admin on Mon Mar 31 20:34:54 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY